Reduced-intensity conditioning for allogeneic stem-cell transplantation (SCT) with fludarabine and intravenous busulfan is associated with improved toxicity profile and longer survival than conditioning with fludarabine and melphalan in patients with chemo-sensitive hematological malignancies

被引：0
|
作者：
Shimoni, Avichai [1 ]
Hardan, Izhar [1 ]
Rand, Avital [1 ]
Shem-Tov, Noga [1 ]
Yerushalmi, Ronit [1 ]
Nagler, Arnon [1 ]
机构：
[1] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2002
引用
收藏
页码：596A / 596A
页数：1
相关论文
共 50 条
  • [31] Reduced-intensity conditioning regimen with thiotepa and fludarabine followed by allogeneic blood stem cell transplantation in haematological malignancies
    E P Alessandrino
    P Bernasconi
    A A Colombo
    D Caldera
    L Malcovati
    D Troletti
    L Vanelli
    M Varettoni
    F Montanari
    M Lazzarino
    Bone Marrow Transplantation, 2004, 34 : 1039 - 1045
  • [32] Reduced-intensity conditioning regimen with thiotepa and fludarabine followed by allogeneic blood stem cell transplantation in haematological malignancies
    Alessandrino, EP
    Bernasconi, P
    Colombo, AA
    Caldera, D
    Malcovati, L
    Troletti, D
    Vanelli, L
    Varettoni, M
    Montanari, F
    Lazzarino, M
    BONE MARROW TRANSPLANTATION, 2004, 34 (12) : 1039 - 1045
  • [33] Relapse of acute myeloid leukemia after allogeneic stem-cell transplantation (SCT) with myeloablative conditioning is associated with longer survival than relapse after reduced-intensity conditioning (RIC)
    Shimoni, Avichai
    Hardan, Izhar
    Shem-Tov, Noga
    Rand, Avital
    Ribakovsky, Elena
    Yerushalmi, Ronit
    Nagler, Amon
    BLOOD, 2007, 110 (11) : 492A - 492A
  • [34] RELAPSE OF ACUTE MYELOID LEUKMIA AFTER ALLOGENEIC STEM-CELL TRANSPLANTATION (SCT) WITH MYELOABLATIVE CONDITIONING IS ASSOCIATED WITH LONGER SURVIVAL THAN RELAPSE AFTER REDUCED-INTENSITY CONDITIONING (RIC)
    Shimoni, A.
    Hardan, I
    Shem-Tov, N.
    Rand, A.
    Ribakovsky, E.
    Yerusbalmi, R.
    Nagler, A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 59 - 60
  • [35] Reduced Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes When Compared to Fludarabine and Busulfan Following Allogeneic Hematopoietic Cell Transplantation for Lymphoid Malignancies
    Kennedy, Vanessa E.
    Savani, Bipin N.
    Greer, John P.
    Kassim, Adetola A.
    Engelhardt, Brian G.
    Goodman, Stacey A.
    Sengsayadeth, Salyka M.
    Chinratanalab, Wichai
    Jagasia, Madan H.
    BLOOD, 2015, 126 (23)
  • [36] Impact of age on outcome after allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning with Fludarabine/Busulfan
    Bethge, W. A.
    Federmann, B.
    Helwig, A.
    Faul, C.
    Vogel, W.
    Kanz, L.
    ONKOLOGIE, 2012, 35 : 129 - 129
  • [37] Fludarabine, Antithymocyte Globulin, and Very Low-Dose Busulfan for Reduced-Intensity Conditioning before Allogeneic Stem Cell Transplantation in Patients with Lymphoid Malignancies
    Malard, Florent
    Cahu, Xavier
    Clavert, Aline
    Brissot, Eolia
    Chevallier, Patrice
    Guillaume, Thierry
    Delaunay, Jacques
    Ayari, Sameh
    Dubruille, Viviane
    Mahe, Beatrice
    Gastinne, Thomas
    Blin, Nicolas
    Harousseau, Jean-Luc
    Moreau, Philippe
    Miplied, Noel
    Le Gouill, Steven
    Mohty, Mohamad
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (11) : 1698 - 1703
  • [38] Reduced-intensity conditioning with fludarabine, low-dose busulfan and antithymocyte globulin prior to allogeneic stem cell transplantation
    Malard, F.
    Brissot, E.
    Delaunay, J.
    Ayari, S.
    Guillaume, T.
    Chevallier, P.
    Dubruille, V.
    Mahe, B.
    Blin, N.
    Gastinne, T.
    Le Gouill, S.
    Saulquin, B.
    Harousseau, J. L.
    Moreau, P.
    Milpied, N.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S290 - S290
  • [39] Reduced-intensity conditioning with treosulfan and fludarabine prior to allogeneic stem cell transplantation in multiple myeloma patients
    Schmidt-Hieber, M
    Casper, J
    Trenschel, R
    Andreesen, R
    Einsele, H
    Kanz, L
    Fauser, A
    Uharek, L
    Thiel, E
    Blau, I
    BONE MARROW TRANSPLANTATION, 2006, 37 : S195 - S196
  • [40] 400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation
    Sobecks, R. M.
    Dean, R.
    Rybicki, L. A.
    Chan, J.
    Theil, K. S.
    Macklis, R.
    Andresen, S.
    Kalaycio, M.
    Pohlman, B.
    Ferraro, C.
    Cherni, K.
    Sweetenham, J.
    Copelan, E.
    Bolwell, B. J.
    BONE MARROW TRANSPLANTATION, 2008, 42 (11) : 715 - 722
12345